These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 55397)

  • 21. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary specific immune response in vitro to MSV tumor cells.
    Senik A; Hebrero FP; Levy JP
    Int J Cancer; 1975 Dec; 16(6):946-59. PubMed ID: 53210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vivo coating of tumor cells by potentially cytotoxic antitumor antibodies.
    Ran M; Witz IP; Klein G
    Adv Exp Med Biol; 1976; 66():451-6. PubMed ID: 57705
    [No Abstract]   [Full Text] [Related]  

  • 25. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI; Fujimoto S; Sehon AH
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibody.
    Forstrom JW; Nelson KA; Nepom GT; Hellström I; Hellström KE
    Nature; 1983 Jun 16-22; 303(5918):627-9. PubMed ID: 6190090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen.
    Srivastava PK; Das MR
    Int J Cancer; 1984 Mar; 33(3):417-22. PubMed ID: 6698641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor-bound immunoglobulins. I. Further analysis of the characteristics of binding of immunoglobulins to in vivo-grown tumor cells.
    Dorval G; Witz IP; Klein E; Wigzell H
    Int J Cancer; 1976 Jan; 17(1):109-19. PubMed ID: 1248896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic association of the humoral and cellular immune responses of rats to Moloney sarcomas.
    Veit BC; Jones JM; Miller GA; Feldman JD
    Int J Cancer; 1977 Jan; 19(1):97-106. PubMed ID: 401773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples.
    Codington JF; Haavik S; Nikrui N; Kuter I; Vassileva C; Zhang H; Matson S; Chen X; Wu Z
    Cancer; 2002 Feb; 94(3):803-13. PubMed ID: 11857316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
    Henriksen O; Law LW; Appella E
    J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface membrane changes of T cells induced by syngeneic tumour cells. I. Formation and uptake of complexes of Ig and tumour antigens by T cells.
    Dular U; Chow DA; Paraskevas F
    Int J Cancer; 1978 Nov; 22(5):611-20. PubMed ID: 82542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of short-term culture on the sensitivity of MDAY murine tumor cells tolysis mediated by normal rabbit serum.
    Caspi R; Witz IP
    Eur J Immunol; 1976 Mar; 6(3):174-9. PubMed ID: 1033065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological detection of a polyoma-tumor-associated membrane antigen.
    Klein G; Ehlin B; Witz I
    Int J Cancer; 1979 May; 23(5):683-90. PubMed ID: 88422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that blocking factors in the sera of multiparous mice are associated with immunoglobulins.
    Tamerius J; Hellström I; Hellström KE
    Int J Cancer; 1975 Sep; 16(3):456-64. PubMed ID: 1176203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigenic reactivation in vitro of the cytotoxic activity of lymphoid cells from mice bearing syngeneic tumors].
    Schaaf-Lafontaine N
    C R Seances Soc Biol Fil; 1977; 171(3):663-6. PubMed ID: 144008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-bound immunoglobulins: an in vivo phenomenon of masked specificity.
    Dorval G; Wilz IP; Klein E; Wigzell H
    J Natl Cancer Inst; 1976 Mar; 56(3):523-7. PubMed ID: 56447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.